about
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialGenome-wide and fine-resolution association analysis of malaria in West AfricaA phase 3 trial of RTS,S/AS01 malaria vaccine in African infantsPopulation pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patientsIntramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled TrialT cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian childrenEthical data release in genome-wide association studies in developing countriesGenome-wide association study indicates two novel resistance loci for severe malariaImmunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trialStandardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network.Evaluating health research capacity building: an evidence-based toolEvaluation of a learner-designed course for teaching health research skills in GhanaRandomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.The effect of malaria and intestinal helminth coinfection on birth outcomes in Kumasi, Ghana.Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria.Malaria, intestinal helminths and other risk factors for stillbirth in GhanaA -436C>A polymorphism in the human FAS gene promoter associated with severe childhood malariaDelayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study.The prognostic value of measures of acid/base balance in pediatric falciparum malaria, compared with other clinical and laboratory parametersA combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine.Population kinetics, efficacy, and safety of dichloroacetate for lactic acidosis due to severe malaria in children.Mortality patterns and site heterogeneity of severe malaria in African children.Hemoglobin variants and disease manifestations in severe falciparum malaria.Endothelial protein C receptor gene variants not associated with severe malaria in ghanaian children.Severe malaria in children leads to a significant impairment of transitory otoacoustic emissions--a prospective multicenter cohort study.Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial.The genetic risk of acute seizures in African children with falciparum malariaGlucose-6-phosphate dehydrogenase deficiency and reduced haemoglobin levels in African children with severe malaria.Prognostic value of circulating pigmented cells in African children with malariaCharacterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.Lack of Association of CD55 Receptor Genetic Variants and Severe Malaria in Ghanaian Children.Delayed haemolysis after artesunate treatment of severe malaria - review of the literature and perspective.Successful utilization of an electronic pain diary in a multinational phase 3 interventional study of pediatric sickle cell anemia.Capillary refill time as an independent prognostic indicator in severe and complicated malaria.Strengthening public health education in population and reproductive health through an innovative academic partnership in Africa: the Gates partners experience.Cerebral malaria is associated with IgG2 and IgG4 antibody responses to recombinant Plasmodium falciparum RIFIN antigen.FCGR2A functional genetic variant associated with susceptibility to severe malarial anaemia in Ghanaian children.Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria.Promoter polymorphism of the anion-exchange protein 1 associated with severe malarial anemia and fatality.blaCTX-M-15 carried by IncF-type plasmids is the dominant ESBL gene in Escherichia coli and Klebsiella pneumoniae at a hospital in Ghana.
P50
Q24630683-E1F2B611-161A-4B24-A6F7-22AFAC9E985CQ24632119-DF327524-BD1B-45D7-91D2-E0274E138D69Q28278852-3A349EBF-CF3D-4E2A-B61A-30393F8F6B7BQ28469076-9FFA18FC-00D6-4D67-98FC-A7540052912FQ28552379-5902EB0F-0E7A-4018-B23A-5F91AD8029FAQ28740701-7C223F9A-7624-48CD-BA50-F5638CD9F615Q28750293-005D0D33-79E2-4858-92DF-895BB2F5BB47Q28943391-1A6E7ED0-E528-463E-A596-B47CC4776F83Q30991737-762416A9-753F-4B88-B9B1-9945F5ED0A60Q31034787-06D41E76-B9D3-4B96-976A-0BCBAAA5AF02Q33255848-B326FC7D-D039-4843-B530-3F5546FF748BQ33289070-F43EDE36-8427-4B21-99A6-CFC388815F2CQ33508797-7C1F5CD3-EC3B-4469-892F-445CCAB74C20Q33578805-7E87067D-29B3-4E37-84F7-D997B964D362Q33721915-A1D888E9-A89E-40AE-934F-BA5943AF0C17Q33771921-E2E57872-19CB-4A02-94AA-A9DAE9EBCB4FQ33916803-E7F19E06-9E40-4AB6-A0F7-E70D6F39FE84Q34039470-9A255D25-2C19-44A7-A9F5-491343CFC64EQ34422271-2B073508-267E-4529-A7A9-A48BC61DB44BQ34487139-3A78C0D3-ADF7-4BDB-8227-8EAF06943FA6Q34533270-B6C7830A-B9D6-47FC-83AB-380F9C521F03Q34625988-21E34EEE-1EE5-4021-9D5B-D384B17FB9F3Q34630890-66FBAB68-E0D6-4A05-BB8C-B09729690D03Q35534205-43391FB7-9271-4EE6-8921-1F7614FC1A37Q35645341-007588A1-E100-46FF-A2E9-1E3D44F0D4ABQ35845345-5BAAD823-6F09-4EDF-9DD9-B3147D3FBF8CQ37073067-FA8DFACF-D5B0-4C37-8FD3-336405BC2C8AQ37077031-2C3E2F7A-AE99-44B7-98CA-3EFDB483CE1AQ37127577-471EA1F9-494C-4396-ADE2-82D219D3944CQ37574319-3AC32439-D3A6-4E1F-92BF-2D75BEE8B029Q37693494-26C7CD98-3677-4CEC-8F67-9909D76C89EAQ38392228-D39D5971-84D5-45E1-B893-196A6B3C22FDQ38661953-22999CE3-A4C5-4176-8B05-7765856BC601Q38996360-8EC54B18-5117-437E-A78C-4027B221FAB6Q39325176-98AB15D7-4AED-4D8B-A1B0-B917D6BD6668Q39439158-10A17A6E-1854-4071-A2C3-74AE43F012C1Q39439776-47EA5BD5-FED8-4262-B829-906DFDC7E7CAQ39525776-28493445-ED64-4C7D-85FA-B76EE516B8CEQ39564705-77ED8097-FB1E-4ECB-A93E-F5E2C84D27A1Q40810809-C15FF2E1-F721-421E-9B46-8854FAD3AFDE
P50
name
Tsiri Agbenyega
@en
Tsiri Agbenyega
@nl
type
label
Tsiri Agbenyega
@en
Tsiri Agbenyega
@nl
prefLabel
Tsiri Agbenyega
@en
Tsiri Agbenyega
@nl